Exome Asset Management
Fund of fundsNew York · Growth–Late Stage
Find your way into Exome Asset Management
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×1
HQs:China×1United States×1
Investments · 2 tracked
founders shown can be your intro pathGracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases.
BiotechHealthtechMedical DevicesSuzhou, CN
Co-investorsLAVLilly Asia VenturesOrbiMedJanus Henderson InvestorsPivotal Life SciencesRA Capital+2 more
Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development.
BiotechHealthtechBaltimore, US
James N. Campbell(President, Chief Scientific Officer)inKerrie L. Brady(Executive Officer)inGregg Beloff(Executive Officer)Jeffrey B. Kindler(Chief Executive Officer)inCharles Oh(Chief Medical Officer)inSmital Shah(Acting CBO)in
Co-investorsCatalio Capital Management, LPEFung CapitalNew Enterprise Associates (NEA)Quan Capital6 Dimensions Capital
Portfolio news
latest coverage across their companiesCentrexion Therapeutics · trysignalbase.com · Mar 25, 2026
Frequently asked questions
- What stage does Exome Asset Management invest at?
- Exome Asset Management invests at the Growth, Late Stage stages.
- What sectors does Exome Asset Management focus on?
- Exome Asset Management focuses on Healthtech.
- Where is Exome Asset Management located?
- Exome Asset Management is headquartered in New York, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Balderton Capital is a European venture capital firm that backs technology startups.